| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.0094 | 0.9 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |